Combined Salmonella and Pasteurella multocida Antigens Single-Dose and Adsorbed in Aluminum Hydroxide–Chitosan Protect Swiss Mice Against Lethal Challenge

Background/Objectives: Avian cholera and typhoid are major bacterial diseases in the poultry industry, causing reduced productivity and economic losses. Here, we developed a single-dose, bivalent, inactivated vaccine. Methods: Different concentrations of the experimental vaccine containing Pasteurella multocida (P. multocida) and Salmonella Gallinarum (S. Gallinarum) antigens adsorbed to an aqueous matrix based on chitosan, aluminum hydroxide, and saponin were evaluated in mice to determine the optimal single-dose concentration. Results: Vaccine efficacy was assessed by survival rates; the experimental vaccine provided complete protection, whereas 67% of animals immunized with a commercial vaccine survived a challenge with 1 × 1010 CFU/mL (2 × 109 CFU/mice) of P. multocida and 5 × 1010 CFU/mL (1 × 1010 CFU/mice) of S. Gallinarum. Subsequently, experiments were conducted to determine the cytokine profiles of animals immunized with the experimental vaccine (single-dose vs. double-dose regimens) followed by a challenge. Pre-challenge cytokine analysis revealed similar profiles for interleukin (IL)-2, IL-4, IL-10, IL-17, interferon gamma (IFN-γ), and Tumor necrosis factor (TNF-α) across groups; however, IL-6 levels were significantly higher in the single-dose experimental vaccine group (G1) than in the commercial vaccine group (G2). In the post-challenge comparative study, the cytokine response induced by the single-dose vaccine was robust and stable, showing no negative interference following the S. Gallinarum challenge, although the double-dose regimen did boost cellular and regulatory cytokines (IFN-γ, TNF-α, and IL-10) specifically against S. Gallinarum. Conversely, no significant differences in cytokine profiles were observed among the treatments for groups challenged with P. multocida or for unchallenged groups. Conclusions: The single-dose regimen proved sufficient to confer complete protective immunity against both pathogens, suggesting it is a promising strategy for simultaneously preventing avian typhoid and cholera.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2026-10-27
DOI
https://doi.org/10.3390/vaccines14110931
Primary Topic
Microbial infections and disease research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combined Salmonella and Pasteurella multocida Antigens Single-Dose and Adsorbed in Aluminum Hydroxide–Chitosan Protect Swiss Mice Against Lethal Challenge

Luís André Morais Mariúba, Wellington S. Moura, Vanessa Mara Chapla, Edson W. S. Cangussu et al.
Vaccines
Microbial infections and disease research
article

Combined Salmonella and Pasteurella multocida Antigens Single-Dose and Adsorbed in Aluminum Hydroxide–Chitosan Protect Swiss Mice Against Lethal Challenge

Luís André Morais Mariúba, Wellington S. Moura, Vanessa Mara Chapla, Edson W. S. Cangussu, Yury Oliveira Chaves, Lucas Samuel Soares dos Santos, Marcos Gontijo da Silva, Paulo Afonso Nogueira, Gil Rodrigues dos Santos, Igor Viana Brandi, Kelvinson Fernandes Viana, Vladimir Pinheiro do Nascimento, Túllio Teixeira Deusdará, Hamilton Santana Brito, Alex Sander Rodrigues Cangussu, Benedito Albuquerque, Frederico Eugênio, Marcela Oliveira Ferreira, Raynne Oliveira Alves, Gessyk Monteiro Marques, Keoma D. P. Cangussu, Ana A. S. Baptista
article en

Abstract

Background/Objectives: Avian cholera and typhoid are major bacterial diseases in the poultry industry, causing reduced productivity and economic losses. Here, we developed a single-dose, bivalent, inactivated vaccine. Methods: Different concentrations of the experimental vaccine containing Pasteurella multocida (P. multocida) and Salmonella Gallinarum (S. Gallinarum) antigens adsorbed to an aqueous matrix based on chitosan, aluminum hydroxide, and saponin were evaluated in mice to determine the optimal single-dose concentration. Results: Vaccine efficacy was assessed by survival rates; the experimental vaccine provided complete protection, whereas 67% of animals immunized with a commercial vaccine survived a challenge with 1 × 1010 CFU/mL (2 × 109 CFU/mice) of P. multocida and 5 × 1010 CFU/mL (1 × 1010 CFU/mice) of S. Gallinarum. Subsequently, experiments were conducted to determine the cytokine profiles of animals immunized with the experimental vaccine (single-dose vs. double-dose regimens) followed by a challenge. Pre-challenge cytokine analysis revealed similar profiles for interleukin (IL)-2, IL-4, IL-10, IL-17, interferon gamma (IFN-γ), and Tumor necrosis factor (TNF-α) across groups; however, IL-6 levels were significantly higher in the single-dose experimental vaccine group (G1) than in the commercial vaccine group (G2). In the post-challenge comparative study, the cytokine response induced by the single-dose vaccine was robust and stable, showing no negative interference following the S. Gallinarum challenge, although the double-dose regimen did boost cellular and regulatory cytokines (IFN-γ, TNF-α, and IL-10) specifically against S. Gallinarum. Conversely, no significant differences in cytokine profiles were observed among the treatments for groups challenged with P. multocida or for unchallenged groups. Conclusions: The single-dose regimen proved sufficient to confer complete protective immunity against both pathogens, suggesting it is a promising strategy for simultaneously preventing avian typhoid and cholera.

VaccinesVol. 14(11)
Universidade Federal de Minas Gerais (BR), Universidade Estadual de Londrina (BR), Universidade Federal do Rio Grande do Sul (BR), Universidade Federal da Integração Latino-Americana (BR), Instituto Nacional de Pesquisas da Amazônia (BR), Universidade Federal do Tocantins (BR), Universidade Estadual de Montes Claros (BR), Fiocruz Amazônia (BR), Fiocruz Rondônia (BR)
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Financiadora de Estudos e Projetos
Good health and well-being, Zero hunger
Openalex Percentile: Top 14%
Microbial infections and disease research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon